Formulation and evaluation
of hydroalcoholic extract of Berberis
aristata DC. and Punica granatum Linn.
for anti-acne action
Karodi Revan1*
Mahendrakumar C.B.2, Bhise Kiran3
1Padm. Dr. D.Y. Patil College
of Pharmacy, Akurdi, Pune, Maharashtra – 411044. (India)
2St. Mary College of
Pharmacy, Secunderabad, Andhra Pradesh – 500085. (India)
3MCE Socy’s Allana College of
Pharmacy, Camp, Pune, Maharashtra- 411001. (India)
*Corresponding Author E-mail: revankarodi@yahoo.co.in
ABSTRACT:
Traditional medicine is the
synthesis of therapeutic experience of generations of practicing physicians of
indigenous systems of medicine. Throughout the history of mankind, many
infectious diseases have been treated with herbals. The traditional medicine is
increasingly solicited through the traditional practitioners and herbalists in
the treatment of infectious diseases. Two such folklore plants which have
number of traditional uses are Punica
granatum linn, and Berberis aristata
DC of punicaceae and berberidaceae family respectively. Berberis aristata has
played a prominent role in herbal healing for more than 2,500 years. The
ancient Egyptians used it to prevent plagues. In India’s it is used for
dysentery, antibacterial infection, inflammations, high blood pressure, and for
abnormal uterine bleeding. Decoction of roots of Berberis aristata is used for skin troubles and in blood
purification. The synergistic action of berberine chemical constituents are to
be superior to that of single constituents. Acne vulgaris is the most common
dermatological disorder amongst teenagers which they don’t like. Therefore as
per the claim into the ancient text the current research was focused on
formulation and evaluation of extract of Punica
granatum linn. and Berberis aristata
DC. for antiacne screening. The fingerprinting and spectroscopic analysis of
the extract was determined. The extracts were also evaluated for antioxidant
and lipid peroxidation activity by 1, 1- diphenyl-2-picryl-hydrazyl and TBARs
method respectively. The study throws a limelight on use of Punica granatum linn. and Berberis aristata DC.in prevention and
treatment of acne with the goal of elucidating the active potential compounds.
KEYWORDS: Berberis
aristata DC, Broth dilution, cup plate method, High performance thin layer
chromatography, 1- diphenyl-2-picryl-hydrazyl method.
INTRODUCTION:
Acne vulgaris is the most common disorder of human
skin that affects upto 80% of individuals in their lives. The area’s most
vulnerable to acne are the largest oil secreting glands present in the face,
back and trunk. It is a chronic inflammatory disease of multifactorial etiology
affecting more than 85% of teenagers and frequently continues into adulthood.
The influencing factors of acne include excess
sebum secretion, hyperkeratinisation of the hair follicle, oxidative stress and
the release of inflammatory mediators 1. Benzoyl peroxide is a potent
oxidizing agent with antibacterial and keratolytic properties. The main adverse
effects are bleaching of clothes, transient skin irritation, and occasional
allergic contact dermatitis. Topical retinoid preparations are useful for mild
to moderate acne and can be applied once or twice daily. Side effects include
erythema, desquamation 2. Topical antibiotics are particularly
useful in mild to moderate acne and in acne which is resistant to benzoyl
peroxide. The development of antibiotic resistance in P. acne may limit the
prescription of topical antibiotics. Follicular
keratinisation, seborrhoea, and colonisation of the pilosebaceous unit with
Propionibacterium acne are central to the development of lesions. Genetic and
hormonal factors also play a role, possibly by optimising the follicular
environment suitable for the growth of P. acne or by influencing the
inflammatory response and thus the nature of the lesions. Such understanding
has led to the use of antibiotics, sebum reducing agents and anti-androgens and
estrogens in conventional treatments3-6.
Herbal plants used in folk medicine
have been accepted as one of the main sources of drug discovery and their
development. The pomegranate is an
ancient, mystical, unique fruit used in several systems of medicine for a
variety of ailments7. The synergistic action of the pomegranate
constituents appears to be superior to that of single constituents. The
potential therapeutic properties of pomegranate are wide-ranging and include
treatment and prevention of cancer, cardiovascular disease, diabetes, dental
conditions, erectile dysfunction, and protection from ultraviolet (UV)
radiation. This research indicates the most therapeutically beneficial
pomegranate constituents are ellagic acid, ellagitannins (including
punicalagins), punicic acid, flavonoids, anthocyanidins, anthocyanins, and
estrogenic flavonols and flavones. It has a variety of uses such as blood purifier, in various
skin diseases, immunomodulant, anti-inflammatory and anti-platelet-activating
factor (PAF) 8.
Berberis
aristata DC.(Berberidaceae), known locally as
daruharidra in vernacular languages is an erect glabrous spinescent shrub, 3-6
m in height with obovate to elliptic, subacute to obtuse, entire or toothed
leave commonly used to treat skin diseases, menorrhagia, diarrhea, cholera,
jaundice, eye and ear infections, as well as urinary tract infections. The
decoction of the root is used as a wash for infected wounds and ulcers, and is
said to help healing and promote cicatrisation. B. aristata extracts
have also been reported to cure hepatotoxicity. Despite the medicinal
importance of this plant species, especially root extracts, reports on its
antibacterial and antifungal activities9. The traditional claim on these plants for the root
and fruit rind reveals the anti-acne effect which can reduces the sebum
production. That is why the current
research work is focused to carry out antiacne activity of the extracts as well
as formulation.
The plant
contains tannins, alkaloids, triterpenes and saponins and anti-microbial activities of tannins and
alkaloids are well documented. The growth of many
fungi, yeasts,
bacteria and viruses were inhibited by these phytomarkers.
MATERIALS
AND METHODS:
Plant
Collection and Extraction
The fresh fruit rind of the plant Punica and roots of Berberis
were collected from the local region of
Pune. It was authenticated by Department of Botany, University of Pune (Voucher
No. Bot /35/11). The powder prepared was extracted by maceration with
hydroalcoholic mixture (60:40) for 72 hours.
Histology
Histology was
performed as to know the various structural bodies which are present in the
plant such as crystals, grains and also which is a part of the authentication. The plant specimen of fruit were cut and fixed in FAA
and then infiltration of specimen is carried out by paraffin wax. The specimens
were sectioned with the help of microtome with thickness of 10-12 µm. The
sections were stained with toluidine blue 9. Photographs of
different magnifications were taken with Nikon lab photo 2 microscopic units 10.
Preliminary Phytochemical Screening
The extracts were then subjected to
preliminary phytochemical screening to detect the presence of various
phytoconstituents by various chemical tests 11.
Antiacne
activity of the Extracts:
The
lyophilized cultures of bacteria Propionibacterium acne (MTCC No. 1951)
were procured from Indian Institute of Microbial Technology (IMTECH),
Chandigarh. The dilutions of extract were prepared and brain heart infusion
broth was prepared. Tween 80 and 0.03ml thioglycollic acid per 100 ml was added
in the prepared broth as a reducing agent12. The 25 ml of the medium
was poured in the ten test tubes followed
by sterilization with autoclave
at15 lb pressure and 121oC for 30 minutes. Using sterile pipette exact amount of extract was added as indicated in
the Table 1 and the final volumes were adjusted to 10ml with
medium followed by inoculation of cultures and incubation at 37 oC
for 48 hrs. The growth in the tubes was monitored by turbidity method
and MIC of the extract was determined 13,
14. The extracts also subjected to antiacne activity by Cup plate
diffusion method using Clindamycin as internal standard (positive control) and zone of inhibition
with MIC was determined 15. Both this analysis was performed
thrice to confirm the efficacy of the result.
Fingerprinting
and Spectroscopic analysis:
The extracts and standards then
subjected to fingerprinting analysis. The calibration curves were plotted.
Free
radical scavenging activity:
The
activity was assayed spectrophotometrically by DPPH method. The reduction in
absorbance of DPPH solution (2 mg/ml) was monitored at 516 nm after addition of
various concentrations of test extracts to DPPH reagent and maintaining these
solutions were maintained at room temperature for 5 m before taking the
reading. The EC50 values for test material was calculated from the calibration
curves of concentration of extract (μg/ml) verses % reduction in
absorbance after subjecting to linear regression between 10–80 %. This activity
was expressed as effective concentration at 50% (EC50) that is the
concentration of the test solution required to give a 50% reduction in
absorbance of the test solution as compared to that of blank solution. Ascorbic
acid was used as a positive control.
Lipid
peroxidation inhibitory activity:
The
activity was studied by the method. The reaction mixture contained mice liver
homogenate (0.2 ml, 10% w/v) in 0.15 M KCl,(0.1 ml, 150 μM), Tris buffer
(0.4 ml, pH 7.5) and various concentrations of test extracts. In vitro lipid
peroxidation was initiated by addition of FeSO4.7H2O (0.1
ml, 10 μM) and ascorbic acid (0.1 ml, 100 μM). The reaction mixture
was incubated at 370 for 1 h. After the incubation period, reaction was
terminated by addition of thiobarbituric acid (TBA- 2 ml, 0.8%) and by heating
the contents for 15 min. for development of coloured complex. The lipid
peroxides formed were measured as thiobarbituric acid reacting substances
(TBARs) by method. The tubes were then centrifuged at 4000 rpm for 10 m. and
cooled. The % inhibition of lipid peroxidation was determined by comparing the
results of test compound with those of controls not treated with extracts by
monitoring the colour intensity at 532 nm Curcumin was used as a positive
control. The results were expressed as IC50 value that is the concentration of
extract required for 50 % inhibition of production of lipid peroxides. 16
Formulation and evaluation of Microemulsion:
Required quantity of Surfactant and co-surfactant was
mixed in oil phase under constant
stirring and the aqueous phase containing extracts were poured in to
the oil phase and homogenized using mechanical stirrer. The microemulsion was
formed instantaneously by diffusion of the two phases leading to the formation
of droplets as shown in the following table 1.17 Evaluation was done
by Appearance, pH measurements, Spreadability, Viscosity, Extrudability
and In-vitro drug
diffusion.
Table 1: Formulation of Microemulsion gel of Punica and Berberis
extract
|
Sr. No |
Extract (in %) |
Oil Phase (in %) |
Distilled Water (in %) |
|||
|
A |
B |
Captex |
Tween 80 |
PEG 400 |
||
|
F1 |
1 |
4 |
30 |
20 |
5 |
40 |
|
F2 |
2 |
5 |
30 |
20 |
5 |
38 |
|
F3 |
3 |
6 |
30 |
20 |
5 |
36 |
F1, F2, F3: Formulation, Extract A: Punica,
Extract B: Berberis
RESULT:
Pharmacognostic
Study:
The quality control parameters were established and
proximate analysis found to be significant. Preliminary phytochemical screening
revealed the presence of tannins and alkaloids.
Histology:
The
required samples of different organs were cut and removed from the plant and
fixed in FAA. After 24 hrs of fixing, the specimens were dehydrated with graded
series of tertiary -Butyl alcohol. The fruit or the pericarp is
thick and fleshy and consist of less prominent epidermis or epicarp. Sclerides
are distributed throughout in Mesocarp (Figure 1
and 2).
Figure
1: Histology showing epicarp and mesocarp region of Punica
Fruit rind
Figure 2:
Vascular strands in the mesocarp region of Punica Fruit rind
Figure 3: Circular
section of Berberis root
Figure 4: Parenchyma region with abundant Starch grains
(Berberis root)
Figure 5: Medullary
rays with xylem vessels of Berberis (when treated with Thymol blue)
Figure 6: Entire
transverse section of Berberis root with stratified cork
Screening of
Extract for Antiacne activity
To screen the plant material
for their antiacne activity in vitro
experiments were carried out by using the organism P. acnes 18.
The culture media was standardized using McFarland turbidity standard. The
broth dilution method was used to detect the MIC of the extracts. (Table 2)
Table 2: Protocol for evaluation of MIC by broth dilution
method for both the extracts
|
Sr. No. |
Amount of Extract/ml |
Amount of medium |
Total Vol of Solution (ml) |
Conc. of Extract in final sol (ml) |
|
1 |
0.1 |
9.9 |
10 |
0.1 |
|
2 |
0.2 |
9.8 |
10 |
0.2 |
|
3 |
0.3 |
9.7 |
10 |
0.3 |
|
4 |
0.4 |
9.6 |
10 |
0.4 |
|
5 |
0.5 |
9.5 |
10 |
0.5 |
|
6 |
0.6 |
9.4 |
10 |
0.6 |
|
7 |
0.7 |
9.3 |
10 |
0.7 |
|
8 |
0.8 |
9.2 |
10 |
0.8 |
|
9 |
0.9 |
9.1 |
10 |
0.9 |
|
10 |
1.0 |
9.0 |
10 |
1.0 |
The results as shown in Table 3 depict that the MIC
values of hydroalcoholic extracts of Punica
was found to be 100 mg/ml and for Berberis was found to be 300 mg/ml
respectively 19. The zone of
inhibition was determined by cup plate diffusion method where an
increase in antiacne activity was observed from zone of lysis emphasizes that
the lysis may be due to the active components present in the hydroalcoholic
extract of the plant. All this
analysis has been carried out thrice to confirm the efficacy of the extract.
Table 3. Zone of inhibition by cup plate method
|
Sr. No. |
Amount of Extract/ml (Punica) |
Zone of inhibition in mm for Punica
extract (including borer size) |
Amount of Extract/ml (Berberis) |
Zone of inhibition in mm for Punica
extract (including borer size) |
Amount of Standard drug |
Zone of inhibition For Standard drug |
|
1 |
0.1 |
12 |
0.3 |
9.5 |
0.2 |
11 |
|
2 |
0.2 |
13 |
0.4 |
7.4 |
0.3 |
12 |
|
3 |
0.3 |
14 |
0.5 |
11.4 |
0.4 |
14.5 |
Diameter of standard borer 6
mm, n= 3
Fingerprinting
and Spectroscopic analysis
The extract shows RF
value 0.19 and 0.49 (Graph 1) after fingerprinting analysis which indicates
presence of tannins (Figure 7).
Figure 7:
Fingerprinting analysis for presence of Tannins of Punica (Rf 0.44) and
alkaloids of Berberis (Rf 0.30 and 0.39)
Spectorscopic Analysis
Graph 1: Calibration curve of Punica granatum linn at 269 nm
Graph 2: Calibration curve of Berberis aristata DC.at 340 nm
Free
radical scavenging activity and lipid peroxidation inhibitory activity
Hydroalcoholic
extracts of Punica and Berberis showed a significant free radical scavenging
activity, carried out by DPPH method. The EC50 value was calculated 57.54
μg/ml and R2-0.9757 for Punica granatum linn. extract and 81.39
μg/ml and R2 0.9991 for Berberis
aristata DC extract. The result was compared with ascorbic acid as standard
control (EC50 2.87 μg/ml, R2- 0.9996).
The
lipid peroxidation inhibitory activity of Punica
granatum linn. extract was found to be significant at IC50 value of 138
μg/ml with R2 was 0.9921 and for Berberis aristata DC at 142 μg/ml with R2 0.9928
.The result was compared with Curcumin as standard (IC50 50 μg/ml,
R2-0.9469).
Evaluation of
Formulation
|
Formulations |
Appearance |
pH |
Spreadability (g/sec) |
Extrudability (g) |
Viscosity (cps) |
|
F1 |
** |
6.9± .05 |
40.8± 0.5 |
525.1± 0.2 |
33.5± 0.3 |
|
F2 |
** |
7± .08 |
42.1± 0.8 |
528.5± 0.1 |
34.5± 0.4 |
|
F3 |
*** |
6.8± .07 |
43.9± 0.4 |
532.4± 0.5 |
35.7± 0.9 |
*** = very good, ** = good. n=3
In-vitro drug diffusion
Retention content after 06 Hrs 11.86% n=3
|
F1 |
Sr. No. |
Time |
% drug
release |
|
1 |
15 min |
2.29 |
|
|
2 |
30 min |
4.28 |
|
|
3 |
45 min |
6.77 |
|
|
4 |
01 hour |
7.11 |
|
|
5 |
02 hour |
7.48 |
|
|
6 |
03 hour |
8.99 |
|
|
7 |
04 hour |
10.16 |
|
|
8 |
05 hour |
10.78 |
|
|
9 |
06 hour |
12.80 |
Retention content after 06 Hrs 6.48%
n=3
|
F2 |
Sr. No. |
Time |
% drug
release |
|
1 |
15 min |
1.44 |
|
|
2 |
30 min |
3.36 |
|
|
3 |
45 min |
4.49 |
|
|
4 |
01 hour |
6.77 |
|
|
5 |
02 hour |
6.99 |
|
|
6 |
03 hour |
7.89 |
|
|
7 |
04 hour |
8.37 |
|
|
8 |
05 hour |
9.53 |
|
|
9 |
06 hour |
11.78 |
Retention content after 06 Hrs 4.78% n=3
|
F3 |
Sr.
No. |
Time |
%
drug release |
|
1 |
15 min |
2.34 |
|
|
2 |
30 min |
3.96 |
|
|
3 |
45 min |
4.47 |
|
|
4 |
01 hour |
5.77 |
|
|
5 |
02 hour |
6.10 |
|
|
6 |
03 hour |
6.56 |
|
|
7 |
04 hour |
8.97 |
|
|
8 |
05 hour |
9.83 |
|
|
9 |
06 hour |
11.93 |
DISCUSSION:
The results of
the zone of inhibition for Punica granatum linn and Berberis aristata DC. hydroalcoholic
extract shows good anti-acne activity when compared to standard drug
clindamycin. Thus the targets in the microbial cell could be surface exposed
adhesion, cell wall peptides and membrane bound enzymes. Here tannins in case
of Punica and alkaloids in case of Berberis are the major phytoconstituents
present in this plant which are responsible for anti-acne action due to cell
lysis with leakage of cytoplasmic constituents. The probable mode of action may be the formation of irreversible complexes
with nucleophilic amino acids, often leading to a loss of function of vital
proteins in the microbial organism 20. Both this extracts were shown significant
free radical scavenging and lipid peroxidation activity. As infections
being a major cause of morbidity and mortality in burn patients, the herbal
extract may prevent infection that leads to high risk of sepsis. Thus the
experimental findings may suggest the plant was found to be effective as to inhibit the effect caused by the P.
acnes.
The investigations have revealed as a promising anti-acne agent because it
inhibits the proliferation of Propionibacterium acnes and hence prevents
its consequences. The result of anti-acne activity thus can be expressed in
relation with antioxidant activity which controls the oxidative stress in acne
inflammation.
CONCLUSION:
This study thus
demonstrates the antiacne activity of hydroalcoholic extract which is effective in the treatment acne vulgaris.
ACKNOWLEDGMENT:
Authors
are thankful to Indian
Institute of Microbial Technology (IMTECH) Chandigarh, for providing cultures
of microorganism and also to Anchrom laboratory (Mumbai) for carrying out
fingerprinting analysis.
REFERENCES:
1. Balkrishnan KP and et
al . Antibacterial
activity of certain medicinal plants against acne-inducing bacteria.
International Journal of Pharma and Bio Sciences. 2(3); 2011: 476-481.
2.
Jain A, Basal E.
Inhibition of Propionibacterium acnes-induced mediators of inflammation
by Indian herbs Phytomedicine, 2007; 10:
34–38.
3. Cox PA. Ethno pharmacology and the search for new
drugs, In Bioactive Compounds from Plants, Ciba Foundation Symposium 154, John
Wiley & Sons, Chichester, 1999; 40-55.
4. Kumar MS, Chandrasekhar MJ, B Suresh. Herbal remedies
for acne. Natural product radiance. 4; 2005: 328-334.
5. Martin KW, Ernst E. Herbal medicines for treatment of bacterial
infections: a review of controlled clinical trials. Journal of Antimicrobial Chemotherapy. 51;2003: 241–246.
6. Kumar, Sachidanand YN. Treatment of Acne Vulgaris with
New Polyherbal Formulations, Clarina Cream and Purim Tablets. Indian
Journal of Dermatology. 46(3), 2003: 138-141.
7. Verma S, Singh SP. Current and future status of herbal medicines. Veterinary World. 1(11); 2008: 347-350.
8.
Karodi RS,
Mahendrakumar CB, Bhise KS. Evaluation of anti-acne activity of
hydroalcoholic extract of Punica granatum Linn. Journal of Pharmacognosy
and Phytotherapy. 5(9); 2013:160-163.
9.
Shahid and et al. Ethno botanical studies on Berberis
aristata DC. Root extracts. African Journal
of Biotechnology. 8 (4); 2009: 556-563.
10. Easu K In Plant anatomy. John Wiley and sons. New York,
1964,550.
11. Mukherjee PK. Quality
Control of Herbal Drugs; Business Horizons Pharmaceuticals Publishers:
New Delhi, 2002, 6-22,189-196.
12. Cunliffe WJ, Holland KT,
Bojar R, Levy SF. A randomized, double-blind comparison of a clindamycin
phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with
respect to microbiologic activity and clinical efficacy in the topical
treatment of acne vulgaris. Clin
Therapeutics. 24 (7); 1997: 17–33.
13. Feldman S, Careccia RE,
Barham KL, Hancox J. Diagnosis and treatment of acne. Am J Physician. 69 (9); 2004: 2123–2130.
14. Fogdall RP, Miller RD.
Prolongation of a pancuronium-induced neuromuscular blockade by clindamycin. Anesthesiology. 41 (4); 1974: 407–408.
15. Gemmell CG, O'Dowd A.
Regulation of protein biosynthesis in Staphylococcus aureus by certain
antibiotics: its effect on phagocytosis by leukocytes. J Antimicrobial Chemotherapy. 12 (6); 2007: 87–97.
16. M. Kanlayavattanakul and N. Lourith. Therapeutic agents and herbs in
topical application for acne. Treatment. International Journal of Cosmetic
Science. 33; 2007: 289–297.
17. Murthy et al. Preparation and Physicochemical
characterization of caprylocapryl macrogol -8- glycerides microemulsion for
oral drug delivery. Ars Pharm. 45 (3); 2004: 353-372.
18. Rosso JQ. Evaluating the role of topical therapies in
the management of acne rosacea: focus on combination sodium sulfacetamide and
sulfur formulations. Journal
of Antimicrobial Chemotherapy. 73(1); 2004: 29–33.
19. Leyden J and et al. Comparison of the efficacy and
safety of a combination topical gel formulation of benzoyl peroxide and
clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the
treatments of acne vulgaris. American
Journal of Clin. Dermatol. 2 (1), 2001: 3–9.
20. Gnanamani A, Shanmuga PK, Radhakrishnan N, Babu M.
Antibacterial activity of two plant extracts on eight burn pathogens, Journal
of Ethnopharmacology. 86, 2003: 59-61.
Received on 10.09.2015 Modified on 25.09.2015
Accepted on 28.09.2015 © RJPT All right reserved
Research J. Pharm. and Tech. 8(11): Nov., 2015; Page
1548-1554
DOI: 10.5958/0974-360X.2015.00276.0